Doximity is trading 4.4% down at $25.43, reversing part of the sharp earnings-driven rally from August 7 and August 13.
- No new company-specific announcement or direct August 14 catalyst was identified.
- Wells Fargo’s August 10 downgrade to Underweight, with an $18 price target, remains a potential overhang after the recent surge.
- Available reporting does not directly link the downgrade to today’s decline.